Haemonetics Corporation

HAE | NYSE

Price Alert Chart Builder DCF Calculator

$121.03

+$1.38 (+1.15%)

Nov 2, 2026, 12:36 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 28, 2026	FY 2025 Mar 29, 2025	FY 2024 Mar 31, 2024	FY 2023 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021
Net Income	97.31M	167.68M	117.56M	115.4M	43.38M	79.47M
Depreciation & Amortization	111.72M	115.59M	97.22M	93.31M	97.75M	84.29M
Stock-Based Compensation	33.83M	29.64M	28.33M	25.58M	24.36M	25.52M
Other Working Capital	-39.56M	-34.24M	21.19M	-20.65M	-4.51M	-64.89M
Other Non-Cash Items	74.74M	-23.49M	2.73M	8.48M	16.95M	-919K
Deferred Income Tax	-714K	-15.7M	-1.01M	4.78M	5.01M	-19.87M
Change in Working Capital	-23.65M	-91.98M	-63.07M	25.5M	-15.18M	-59.68M
Operating Cash Flow	293.22M	181.73M	181.75M	273.06M	172.26M	108.81M
Capital Expenditures	-32.78M	-39.28M	-38.13M	-110.19M	-96.51M	-37.04M
Cash Acquisitions	1.38M	-107.62M	-242.35M	-2M	8.14M	-390.22M
Purchase of Investments	n/a	n/a	n/a	-33.21M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-87.96M	-15M	-41.91M	1.61M	2.02M	1.82M
Investing Cash Flow	-179.55M	-161.9M	-322.39M	-143.79M	-86.35M	-425.44M
Debt Repayment	-6.25M	447.31M	37.75M	-9.63M	-17.5M	418.13M
Common Stock Repurchased	-175M	-225M	n/a	-75M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-5.1M	-111.58M	-922K	-15.74M	-4.8M	-50.67M
Financial Cash Flow	-178.46M	108.82M	38.16M	-100.36M	-15.75M	367.45M
Net Cash Flow	-61.32M	127.96M	-105.67M	24.97M	67.19M	54.99M
Free Cash Flow	260.44M	142.45M	143.63M	162.87M	75.75M	71.77M
Adj. Free Cash Flow	226.61M	112.81M	115.29M	137.28M	51.4M	46.25M
Maintenance CapEx	-32.78M	-25.52M	n/a	-57.38M	-57.59M	-37.04M
Growth CapEx	n/a	-13.76M	-38.13M	-52.81M	-38.92M	n/a
Owner Earnings	260.44M	156.2M	181.75M	215.68M	114.67M	71.77M